Beyond SMILES: Evaluating Agentic Systems for Drug Discovery

• URL: http://arxiv.org/abs/2602.10163v1
• Date: Tue, 10 Feb 2026 09:01:09 GMT
• Title: Beyond SMILES: Evaluating Agentic Systems for Drug Discovery
• Abstract summary: Agentic systems for drug discovery have demonstrated autonomous planning, literature mining, and molecular design.<n>We evaluate six frameworks against 15 task classes drawn from peptide therapeutics, in vivo pharmacology, and resource-constrained settings.<n>We find five capability gaps: no support for protein language models or peptide-specific prediction, no bridges between in vivo and in silico data, reliance on LLM inference with no pathway to ML training or reinforcement learning.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Agentic systems for drug discovery have demonstrated autonomous synthesis planning, literature mining, and molecular design. We ask how well they generalize. Evaluating six frameworks against 15 task classes drawn from peptide therapeutics, in vivo pharmacology, and resource-constrained settings, we find five capability gaps: no support for protein language models or peptide-specific prediction, no bridges between in vivo and in silico data, reliance on LLM inference with no pathway to ML training or reinforcement learning, assumptions tied to large-pharma resources, and single-objective optimization that ignores safety-efficacy-stability trade-offs. A paired knowledge-probing experiment suggests the bottleneck is architectural rather than epistemic: four frontier LLMs reason about peptides at levels comparable to small molecules, yet no framework exposes this capability. We propose design requirements and a capability matrix for next-generation frameworks that function as computational partners under realistic constraints.

Related papers

• DrugReason: Dynamic Multi-View Reasoning over Knowledge Graph and Language Evidence for Drug Repurposing [55.45112712244231]
  DrugReason is a multi-view reasoning framework that integrates grounded KG reasoning with LLM-generated mechanistic inference for drug repurposing.<n> Experiments on PharmaDB, DDInter, and DrugBank show that DrugReason improves average performance over strong single-view reasoning baselines.
  arXiv  Detail & Related papers  (2026-09-06T18:54:26Z)
• Epistemic Blinding: An Inference-Time Protocol for Auditing Prior Contamination in LLM-Assisted Analysis [0.0]
  Epistemic blinding is a simple inference-time protocol that replaces entity identifiers with anonymous codes before prompting, then compares outputs against an unblinded control.<n>In oncology drug target prioritization across four cancer types, blinding changes 16% of top-20 predictions while preserving identical recovery of validated targets.<n>In S&P 500 equity screening, brand-recognition bias reshapes 30-40% of top-20 rankings across five random seeds.
  arXiv  Detail & Related papers  (2026-04-07T16:06:52Z)
• DrugR: Optimizing Molecular Drugs through LLM-based Explicit Reasoning [24.70952870676648]
  DrugR is a large language model that introduces explicit, step-by-step pharmacological reasoning into the optimization process.<n>Our approach integrates domain-specific continual pretraining, supervised fine-tuning via reverse data engineering, and self-balanced multi-granular reinforcement learning.<n> Experimental results demonstrate that DrugR achieves comprehensive enhancement across multiple properties without compromising structural similarity or target binding affinity.
  arXiv  Detail & Related papers  (2026-02-09T02:26:25Z)
• Empowering LLMs for Structure-Based Drug Design via Exploration-Augmented Latent Inference [5.052013621974765]
  Large Language Models (LLMs) possess strong representation and reasoning capabilities, but their application to structure-based drug design (SBDD) is limited by insufficient understanding of protein structures and unpredictable molecular generation.<n>We propose Exploration-Augmented Latent Inference for LLMs (ELILLM), a framework that reinterprets the LLM generation process as an encoding, latent space exploration, and decoding workflow.<n>ELILLM explicitly explores portions of the design problem beyond the model's current knowledge while using a decoding module to handle familiar regions, generating chemically valid and synthetically reasonable molecules.
  arXiv  Detail & Related papers  (2026-01-20T08:10:48Z)
• How well can off-the-shelf LLMs elucidate molecular structures from mass spectra using chain-of-thought reasoning? [51.286853421822705]
  Large language models (LLMs) have shown promise for reasoning-intensive scientific tasks, but their capability for chemical interpretation is still unclear.<n>We introduce a Chain-of-Thought (CoT) prompting framework and benchmark that evaluate how LLMs reason about mass spectral data to predict molecular structures.<n>Our evaluation across metrics of SMILES validity, formula consistency, and structural similarity reveals that while LLMs can produce syntactically valid and partially plausible structures, they fail to achieve chemical accuracy or link reasoning to correct molecular predictions.
  arXiv  Detail & Related papers  (2026-01-09T20:08:42Z)
• Lost in Tokenization: Context as the Key to Unlocking Biomolecular Understanding in Scientific LLMs [78.18336140706471]
  Sci-LLMs have emerged as a promising frontier for accelerating biological discovery.<n>Current strategies limit Sci-LLMs' reasoning capacity when processing raw biomolecular sequences.<n>We show that a more effective strategy is to provide Sci-LLMs with high-level structured context.
  arXiv  Detail & Related papers  (2025-10-27T09:03:21Z)
• Zero-Shot Document-Level Biomedical Relation Extraction via Scenario-based Prompt Design in Two-Stage with LLM [6.26004554105527]
  We propose a novel approach to achieve the same results from unannotated full documents using general large language models (LLMs) with lower hardware and labor costs.<n>Our approach combines two major stages: named entity recognition (NER) and relation extraction (RE)<n>To enhance the effectiveness of prompt, we propose a five-part template structure and a scenario-based prompt design principles.
  arXiv  Detail & Related papers  (2025-05-02T07:33:20Z)
• LLM Agent Swarm for Hypothesis-Driven Drug Discovery [2.7036595757881323]
  PharmaSwarm is a unified multi-agent framework that orchestrates specialized "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds.<n>By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
  arXiv  Detail & Related papers  (2025-04-24T22:27:50Z)
• Knowledge Hierarchy Guided Biological-Medical Dataset Distillation for Domain LLM Training [10.701353329227722]
  We propose a framework that automates the distillation of high-quality textual training data from the extensive scientific literature.<n>Our approach self-evaluates and generates questions that are more closely aligned with the biomedical domain.<n>Our approach substantially improves question-answering tasks compared to pre-trained models from the life sciences domain.
  arXiv  Detail & Related papers  (2025-01-25T07:20:44Z)
• Causal Representation Learning from Multimodal Biomedical Observations [57.00712157758845]
  We develop flexible identification conditions for multimodal data and principled methods to facilitate the understanding of biomedical datasets.<n>Key theoretical contribution is the structural sparsity of causal connections between modalities.<n>Results on a real-world human phenotype dataset are consistent with established biomedical research.
  arXiv  Detail & Related papers  (2024-11-10T16:40:27Z)
• Can large language models explore in-context? [87.49311128190143]
  We deploy Large Language Models as agents in simple multi-armed bandit environments. We find that the models do not robustly engage in exploration without substantial interventions.
  arXiv  Detail & Related papers  (2024-03-22T17:50:43Z)
• Large Language Model Distilling Medication Recommendation Model [58.94186280631342]
  We harness the powerful semantic comprehension and input-agnostic characteristics of Large Language Models (LLMs)<n>Our research aims to transform existing medication recommendation methodologies using LLMs.<n>To mitigate this, we have developed a feature-level knowledge distillation technique, which transfers the LLM's proficiency to a more compact model.
  arXiv  Detail & Related papers  (2024-02-05T08:25:22Z)
• Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions [80.12620331438052]
  deep learning has become an important tool for rapid screening of billions of molecules in silico for potential hits containing desired chemical features. Despite its importance, substantial challenges persist in training these models, such as severe class imbalance, high decision thresholds, and lack of ground truth labels in some datasets. We argue in favor of directly optimizing the receiver operating characteristic (ROC) in such cases, due to its robustness to class imbalance.
  arXiv  Detail & Related papers  (2020-06-25T08:46:37Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.